Metflex: The Effectiveness of a Dietary Intervention
Employing Dynamic Kinetic Responses to Demonstrate the Effectiveness of Dietary Intervention: A Challenge-based Study Using a Low-glycaemic Load Diet
1 other identifier
interventional
45
1 country
1
Brief Summary
This study is testing the effectiveness of a dietary intervention by means of measuring the change in RQ upon a hyperinsulinemic euglycemic clamp challenge and by means of measuring the kinetic responses of multiple PF markers (including RQ) to an acute mixed meal challenge before and after a 6-week dietary intervention. The challenges will be applied to investigate whether the kinetic response is a better measure for health and wellbeing when compared to fasting (baseline) levels. In addition, several measures that reflect perceivable benefits like mood, quality of life, sleep quality, cognitive and physical performance will be assessed in a first exploratory attempt to link (changes in) PF to consumer perceivable benefits. Subjects will be randomly allocated to a low glycemic load diet or a 'Western' diet for 6 weeks. Before and after the intervention several measurements will take place. The low glycemic load diet will be high in polyphenols, protein, vegetables, pulses, fibres and nuts, and low in glycemic carbohydrates. All these dietary factors have been shown to improve glycemic control and/or to reduce metabolic syndrome risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 7, 2015
CompletedFirst Posted
Study publicly available on registry
August 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2017
CompletedNovember 9, 2017
November 1, 2017
1.9 years
July 7, 2015
November 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Metabolic flexibility, as measured by delta RQ (change in RQ) upon a hyperinsulinemic euglycemic clamp
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Secondary Outcomes (5)
Metabolic flexibility, as measured by delta RQ (change in RQ) upon a mixed meal challenge
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Phenotypic flexibility markers, as measured by various blood parameters such as lipids, glucose, inflammatory markers and more, upon a mixed meal challenge
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Diet-induced changes in the Kinetic responses vs. the baseline values of RQ and various phenotypic flexibility parameters such as lipids, glucose, inflammatory markers and more
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Phenotypic flexibility markers, as measured by various blood parameters such as lipids, glucose, inflammatory markers and more, in the fasted state
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Insulin sensitivity, as measured by a hyperinsulinemic euglycemic clamp
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Other Outcomes (8)
Functional markers of cognitive performance, as measured by attention, memory and executive function
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Functional markers of physical performance, as measured by the timed up-and-go test (TUGT), the 6-minute walk test, handgrip and muscle strength tests
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
Sleep quality, as assessed with the10-item Pittsburgh Sleep Quality Index
Within 5 days before the start of the 6 week dietary intervention and again in the 6th week of the dietary intervention
- +5 more other outcomes
Study Arms (2)
Low glycaemic load diet
EXPERIMENTALSubjects will be following a low glycaemic load diet, typically high in polyphenols, proteins, vegetables, pulses, fibres and nuts, and low in glycemic carbohydrates, for six continuous weeks.
Western diet
EXPERIMENTALSubjects will be following a western diet, typically high in saturated fat, refined sugars and salt, and low in fruit and vegetables and fibers, for six continuous weeks.
Interventions
Subjects will first be subjected to a 2-week run-in diet consisting of products that fit into a typical 'Western' diet. Thereafter subjects will be allocated to a low glycemic load diet for 6 weeks.
Subjects will first be subjected to a 2-week run-in diet consisting of products that fit into a typical 'Western' diet. Thereafter subjects will be allocated to a 'Western' diet for 6 weeks.
Eligibility Criteria
You may qualify if:
- Signed informed consent
- Men and postmenopausal women: ≥ 50 and ≤ 70 years at the start of the study
- Body mass index (BMI) ≥ 25.0 and ≤ 35.0 kg/m2
- Healthy (as determined by dependent physician): no medical conditions which might affect the study measurements, absorption, metabolism and distribution (including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases) as assessed by physical characteristics and health and lifestyle questionnaire
- Fasting blood glucose value ≤ 6.9 mmol/litre at screening
- Waist circumference \>94 cm for males, \>80 cm for females
- Maximum 2.5 hours of moderate to vigorous physical activity per week (during last 3 months)
- Agreeing to be informed about medically relevant personal test-results by a physician
- Willing to comply to study protocol during study
- Accessible veins on arms as determined by examination at screening
You may not qualify if:
- Reported participation in another nutritional or biomedical trial three months before the pre-study examination or during the study
- Blood donation in the past three months
- Reported participation in night shift work two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM;
- Consumption of \> 21 alcoholic units for males, \> 14 alcohol units for females in a typical week;
- Reported use of any nicotine containing products in the six months preceding the study and during the study itself;
- Reported dietary habits: medically prescribed diet, slimming diet, vegetarian;
- People who are familiar with an allergy or intolerance to any of the provided food products
- Reported weight loss or weight gain (10%) in the last six months prior to the pre-study screening;
- Clinically relevant abnormalities in clinical chemistry at screening (to be judged by the study physician);
- Being an employee of Unilever or the collaborating research departments in Maastricht University Medical Centre (MUMC+);
- Taking medication, which may interfere with study measurements, as judged by the responsible physician;
- Subjects, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maastricht University Medical Centerlead
- Unilever R&Dcollaborator
Study Sites (1)
Maastricht University Medical Center
Maastricht, 6200 MD, Netherlands
Related Publications (2)
Fechner E, Bilet L, Peters HPF, Schrauwen P, Mensink RP. A Whole-Diet Approach Affects Not Only Fasting but Also Postprandial Cardiometabolic Risk Markers in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2020 Nov 19;150(11):2942-2949. doi: 10.1093/jn/nxaa252.
PMID: 33096554DERIVEDFechner E, Bilet L, Peters HPF, Hiemstra H, Jacobs DM, Op 't Eyndt C, Kornips E, Mensink RP, Schrauwen P. Effects of a whole diet approach on metabolic flexibility, insulin sensitivity and postprandial glucose responses in overweight and obese adults - A randomized controlled trial. Clin Nutr. 2020 Sep;39(9):2734-2742. doi: 10.1016/j.clnu.2019.12.010. Epub 2019 Dec 17.
PMID: 31899037DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Schrauwen, Professor
Maastricht University Medical Center
- PRINCIPAL INVESTIGATOR
Ronald Mensink, Professor
Maastricht University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2015
First Posted
August 10, 2015
Study Start
July 1, 2015
Primary Completion
May 12, 2017
Study Completion
May 12, 2017
Last Updated
November 9, 2017
Record last verified: 2017-11